Issuer Newsroom

Trinity PR on behalf of Contura Orthopaedics Ltd

Wire Volume: 1 Disclosures

Corporate Disclosures & Press Wire (1)

New ‘White Paper’ explores the injection set to redefine the treatment of knee osteoarthritis and unlock access to non-surgical options for NHS patients
London - April 15 2026··Company News

New ‘White Paper’ explores the injection set to redefine the treatment of knee osteoarthritis and unlock access to non-surgical options for NHS patients

A new white paper titled "Inside the Science: A Major Step Forward for Knee Osteoarthritis" has been released, highlighting Arthrosamid®, an injectable hydrogel as a promising non-surgical treatment for knee osteoarthritis. Commissioned by Contura Orthopaedics Ltd, the report suggests that Arthrosamid® could provide a viable alternative to surgery, potentially easing the NHS backlog of patients awaiting joint treatment. The paper discusses ongoing research and trials that support the hydrogel's

Read disclosure →